Literature DB >> 30102167

Reporting of immune checkpoint inhibitor-associated myocarditis.

Sadeer G Al-Kindi1, Guilherme H Oliveira2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30102167     DOI： 10.1016/S0140-6736(18)31542-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  11 in total

1.  Pharmacogenomics for immunotherapy and immune-related cardiotoxicity.

Authors:  Jessica A Castrillon; Charis Eng; Feixiong Cheng
Journal:  Hum Mol Genet       Date:  2020-10-20       Impact factor: 6.150

2.  Brazilian Society of Cardiology Guideline on Myocarditis - 2022.

Authors:  Marcelo Westerlund Montera; Fabiana G Marcondes-Braga; Marcus Vinícius Simões; Lídia Ana Zytynski Moura; Fabio Fernandes; Sandrigo Mangine; Amarino Carvalho de Oliveira Júnior; Aurea Lucia Alves de Azevedo Grippa de Souza; Bárbara Maria Ianni; Carlos Eduardo Rochitte; Claudio Tinoco Mesquita; Clerio F de Azevedo Filho; Dhayn Cassi de Almeida Freitas; Dirceu Thiago Pessoa de Melo; Edimar Alcides Bocchi; Estela Suzana Kleiman Horowitz; Evandro Tinoco Mesquita; Guilherme H Oliveira; Humberto Villacorta; João Manoel Rossi Neto; João Marcos Bemfica Barbosa; José Albuquerque de Figueiredo Neto; Louise Freire Luiz; Ludhmila Abrahão Hajjar; Luis Beck-da-Silva; Luiz Antonio de Almeida Campos; Luiz Cláudio Danzmann; Marcelo Imbroise Bittencourt; Marcelo Iorio Garcia; Monica Samuel Avila; Nadine Oliveira Clausell; Nilson Araujo de Oliveira; Odilson Marcos Silvestre; Olga Ferreira de Souza; Ricardo Mourilhe-Rocha; Roberto Kalil Filho; Sadeer G Al-Kindi; Salvador Rassi; Silvia Marinho Martins Alves; Silvia Moreira Ayub Ferreira; Stéphanie Itala Rizk; Tiago Azevedo Costa Mattos; Vitor Barzilai; Wolney de Andrade Martins; Heinz-Peter Schultheiss
Journal:  Arq Bras Cardiol       Date:  2022-07       Impact factor: 2.667

Review 3.  Neurology of cancer immunotherapy.

Authors:  Amedeo De Grado; Federica Cencini; Alberto Priori
Journal:  Neurol Sci       Date:  2022-09-16       Impact factor: 3.830

Review 4.  What the Cardiologist Needs to Know About Cancer Immunotherapies and Complications.

Authors:  Marina Frayberg; Anthony Yung; Leyre Zubiri; Daniel A Zlotoff; Kerry L Reynolds
Journal:  Curr Treat Options Oncol       Date:  2021-05-26

5.  Myocarditis occurrence with cancer immunotherapy across indications in clinical trial and post-marketing data.

Authors:  Tigran Makunts; Ila M Saunders; Isaac V Cohen; Mengxing Li; Talar Moumedjian; Masara A Issa; Keith Burkhart; Peter Lee; Sandip Pravin Patel; Ruben Abagyan
Journal:  Sci Rep       Date:  2021-08-30       Impact factor: 4.379

6.  Case Series of Steroid-Resistant Immune Checkpoint Inhibitor Associated Myocarditis: A Comparative Analysis of Corticosteroid and Tofacitinib Treatment.

Authors:  Cong Wang; Jinyi Lin; Yan Wang; David H Hsi; Jiahui Chen; Tianshu Liu; Yuhong Zhou; Zhenggang Ren; Zhaochong Zeng; Leilei Cheng; Junbo Ge
Journal:  Front Pharmacol       Date:  2021-12-06       Impact factor: 5.810

Review 7.  Advances in Knowledge and Management of Immune-Related Adverse Events in Cancer Immunotherapy.

Authors:  T Anders Olsen; Tony Zibo Zhuang; Sarah Caulfield; Dylan J Martini; Jacqueline T Brown; Bradley C Carthon; Omer Kucuk; Wayne Harris; Mehmet Asim Bilen; Bassel Nazha
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-22       Impact factor: 5.555

8.  Detecting and Filtering Immune-Related Adverse Events Signal Based on Text Mining and Observational Health Data Sciences and Informatics Common Data Model: Framework Development Study.

Authors:  Yue Yu; Kathryn Ruddy; Aaron Mansfield; Nansu Zong; Andrew Wen; Shintaro Tsuji; Ming Huang; Hongfang Liu; Nilay Shah; Guoqian Jiang
Journal:  JMIR Med Inform       Date:  2020-06-12

Review 9.  Immune Checkpoint Inhibitor Myocarditis: Pathophysiological Characteristics, Diagnosis, and Treatment.

Authors:  Nicolas Palaskas; Juan Lopez-Mattei; Jean Bernard Durand; Cezar Iliescu; Anita Deswal
Journal:  J Am Heart Assoc       Date:  2020-01-21       Impact factor: 5.501

10.  [Cardiotoxicity of Anti-PD-L1 Antibody and the Effect of Levothyroxine 
in Attenuating the Related Mortality in Mice].

Authors:  Zhenyin Chen; Min Wang; Sanhui Gao; Hua Guo; Guizhen Wang; Guangbiao Zhou
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2021-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.